Previous 10 | Next 10 |
Q4 2022 reported revenue of $293.4 million, up 5.4% compared to Q4 2021 Q4 2022 constant currency revenue, organic* up 8.2% compared to Q4 2021 Q4 2022 GAAP operating margin of 10.4%, compared to 7.9% in Q4 2021 Q4 2022 non-GAAP operating margin* of 17.8%, compared to 17.4% in Q4 2021...
Merit Medical Systems ( NASDAQ: MMSI ) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, after market close. The consensus EPS Estimate is $0.67 (-5.6% Y/Y) and the consensus Revenue Estimate is $290.14M (+4.2% Y/Y). Over the last 2 years, MMSI has be...
SOUTH JORDAN, Utah, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the FDA has granted Breakthrough Device Designation for the SCOUT MD Surgical Guidance System. The SCOUT MD ...
SOUTH JORDAN, Utah, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2022, and issue fisc...
Summary Jeff Smith’s 13F portfolio value decreased from $5.50B to $4.55B this quarter. Starboard Value added Wix.com while decreasing ON Semiconductor and Huntsman Corp. The largest three individual stock positions are GoDaddy, Aecom, and Humana. They add up to ~34% of the po...
Summary Meridian Funds, advised by ArrowMark, are actively managed and focus on market segments and industries that offer the ability to gain a distinct competitive advantage. Our long-only equity strategies primarily focus on the U.S. small- and mid-capitalization universe. The Meridia...
SOUTH JORDAN, Utah, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the successful enrollment of the first patient in its prospective, observational study of EmboCube Embolization Ge...
SOUTH JORDAN, Utah, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the basixALPHA™ Inflation Device. The basixALPHA is the latest addit...
SOUTH JORDAN, Utah, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced that Fred Lampropoulos, Merit’s Chairman and CEO, received the 2022 Manufacturing Leader of the Year Award ...
SOUTH JORDAN, Utah, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the PreludeSYNC EZ™ Radial Compression Device. The new device is the...
News, Short Squeeze, Breakout and More Instantly...
Merit Medical Systems Inc. Company Name:
MMSI Stock Symbol:
NASDAQ Market:
Merit Medical Systems Inc. Website:
Asset acquisition expands Merit’s endoscopy portfolio with a minimally invasive solution for patients suffering from chronic gastroesophageal reflux disease (GERD). Asset acquisition projected to add approximately $30 million of revenue, on an annualized basis, in key gastroint...
2024-06-23 06:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2024, after the close of the stock marke...